Status:
COMPLETED
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
McGill University
University of Arizona
Conditions:
Severe Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Sepsis is a significant cause health care expenditure and carries an extremely high rate of morbidity and mortality if not treated appropriately. From 1979 to 2000, sepsis resulted in over 10 million ...
Eligibility Criteria
Inclusion
- Patients greater than 18 years of age who present to the emergency department with the diagnosis of severe sepsis/septic shock.
- This will include patients that have 2/4 systemic inflammatory response syndrome criteria, a suspected infection and either a initial serum lactate \> 4mmol/L or a initial systolic blood pressure \< 90 millimeters of mercury.
Exclusion
- Patients in whom antibiotics have been administered \>2 hours prior to assessment.
- Patients with antibiotics in the community in the past 48 hours
- Patients with known severe coagulopathy
Key Trial Info
Start Date :
March 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 10 2019
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT01867905
Start Date
March 1 2014
End Date
April 10 2019
Last Update
April 16 2019
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Maricopa Integrated Health Center
Phoenix, Arizona, United States, 85008
2
Lions Gate Hospital
North Vancouver, British Columbia, Canada, V7L 2L7
3
Surrey Memorial Hospital
Surrey, British Columbia, Canada, V3V 1Z2
4
Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 1M9